1-3 of 3
acute type b viral hepatitis
Close
Sort by
Journal Articles

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Muhned Alhumaid, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Hazzaa Alzahrani, MD, Naeem A. Chaudhri, MD, Raid El Fakih, MD, Amr Hanbali, MD, Shahrukh K. Hashmi, MDMPH, Said Yousuf Ahmed, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Marwan Shaheen, MD, Tusneem Elhassan, MSc, Feras Abdulaziz Alfraih, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5498.
https://doi.org/10.1182/blood.V130.Suppl_1.5498.5498
Published: 2017
Journal Articles

Hepatotoxicity Profile of Single Agent As 2 O 3 in the Management of Newly Diagnosed Cases of Acute Promyelocytic Leukemia: Impact on Outcome and Correlation with Genetic Polymorphisms.

Vikram Mathews, MD, Salamun, MSc, Biju George, MD, Auro Viswabandya, MD, Kavitha M. Lakshmi, MSc, Ashish Bajel, MD, Alok Srivastava, MD, Mammen Chandy, MD
Journal: Blood
Blood (2005) 106 (11): 893.
https://doi.org/10.1182/blood.V106.11.893.893
Published: 2005
Journal Articles

Hepatitis B Virus Reactivation and Alemtuzumab Therapy.

Emilio Iannitto, MD, Viviana Minardi, MD, Giuseppina Calvaruso, MD, Antonino Mulè, MD, Donatella Ferraro, PhD, Emanuele Ammatuna, MD, Antonio Craxì, MD, Vincenzo Abbadessa, MD, Rosellina Di Stefano
Journal: Blood
Blood (2004) 104 (11): 4816.
https://doi.org/10.1182/blood.V104.11.4816.4816
Published: 2004